Insights into the Target Interaction of Naturally Occurring Muraymycin Nucleoside Antibiotics-Reference-Cited by-同舟云学术

Insights into the Target Interaction of Naturally Occurring Muraymycin Nucleoside Antibiotics

Published:2018-03-23 Issue:8 Volume:13 Page:779-784
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Koppermann Stefan¹^ORCID,Cui Zheng²,Fischer Patrick D.¹,Wang Xiachang³⁴^ORCID,Ludwig Jannine¹,Thorson Jon S.²⁴^ORCID,Van Lanen Steven G.²,Ducho Christian¹^ORCID

Affiliation:

1. Department of Pharmacy, Pharmaceutical and Medicinal Chemistry; Saarland University; Campus C2 3 66123 Saarbrücken Germany

2. Department of Pharmaceutical Sciences, College of Pharmacy; University of Kentucky; 789 S. Limestone Street Lexington KY 40536 USA

3. Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, School of Pharmacy; Nanjing University of Chinese Medicine; Nanjing 210023 P.R. China

4. Center for Pharmaceutical Research and Innovation, College of Pharmacy; University of Kentucky; 789 S. Limestone Street Lexington KY 40536 USA

Funder

Deutsche Forschungsgemeinschaft

University of Kentucky College of Pharmacy

University of Kentucky Markey Cancer Center

National Center for Advancing Translational Sciences

National Institutes of Health

Fonds der Chemischen Industrie

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference52 articles.

1. The Bacteria Fight Back

2. Fix the antibiotics pipeline

3. MraY Inhibitors as Novel Antibacterial Agents

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding structural diversity of 5′-aminouridine moiety of sansanmycin via mutational biosynthesis;Frontiers in Bioengineering and Biotechnology;2023-10-30

2. Nucleoside-derived inhibitors of MraY: Medicinal chemistry with natural products;New Approaches Towards Novel Antibacterial Agents;2023

3. The challenges and opportunities of developing small molecule inhibitors of MraY;New Approaches Towards Novel Antibacterial Agents;2023

4. Synthesis of an Antimicrobial Enterobactin‐Muraymycin Conjugate for Improved Activity Against Gram‐Negative Bacteria;Chemistry – A European Journal;2022-12-05

5. A Sub-Micromolar MraYAA Inhibitor with an Aminoribosyl Uridine Structure and a (S,S)-Tartaric Diamide: Synthesis, Biological Evaluation and Molecular Modeling;Molecules;2022-03-08